Biomark Capital
Overview
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures.
Investment Focus
- Highly Disruptive Innovation
- Large Clinical Unmet Medical Need
- Freedom-to-Operate / Large Barriers to Entry
- Established Proof-of-Concept
- Strong Management Team
Portfolio Companies
Reach Biomark Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Biomark Capital
What sectors does Biomark Capital invest in?
Biomark Capital invests in Healthcare, Life Sciences, Digital Health, Medical Devices, Diagnostics and Information Technology, and is based in California, United States. Biomark Capital is listed as a vc in the ConnectSafely investor database.
What stage does Biomark Capital invest at?
Biomark Capital backs companies at Early Stage and Late Stage, writing cheques of 5M - 10M.
Which regions does Biomark Capital invest in?
Biomark Capital invests across United States, China, India, Russia and Taiwan.
What companies has Biomark Capital invested in?
Biomark Capital's portfolio includes Strand Life Sciences and Meril Life Sciences.
How do I contact Biomark Capital?
Biomark Capital's contact details — including phone — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
